Effectiveness of a Multicomponent Quality Improvement Strategy to Improve Achievement of Diabetes Care Goals: A Randomized, Controlled Trial
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Achievement of diabetes care goals is suboptimal globally. Diabetes-focused quality improvement (QI) is effective but remains untested in South Asia. OBJECTIVE: To compare the effect of a multicomponent QI strategy versus usual care on cardiometabolic profiles in patients with poorly controlled diabetes. DESIGN: Parallel, open-label, pragmatic randomized, controlled trial. (ClinicalTrials.gov: NCT01212328). SETTING: Diabetes clinics in India and Pakistan. PATIENTS: 1146 patients (575 in the intervention group and 571 in the usual care group) with type 2 diabetes and poor cardiometabolic profiles (glycated hemoglobin [HbA1c] level ≥8% plus systolic blood pressure [BP] ≥140 mm Hg and/or low-density lipoprotein cholesterol [LDLc] level ≥130 mg/dL). INTERVENTION: Multicomponent QI strategy comprising nonphysician care coordinators and decision-support electronic health records. MEASUREMENTS: Proportions achieving HbA1c level less than 7% plus BP less than 130/80 mm Hg and/or LDLc level less than 100 mg/dL (primary outcome); mean risk factor reductions, health-related quality of life (HRQL), and treatment satisfaction (secondary outcomes). RESULTS: Baseline characteristics were similar between groups. Median diabetes duration was 7.0 years; 6.8% and 39.4% of participants had preexisting cardiovascular and microvascular disease, respectively; mean HbA1c level was 9.9%; mean BP was 143.3/81.7 mm Hg; and mean LDLc level was 122.4 mg/dL. Over a median of 28 months, a greater percentage of intervention participants achieved the primary outcome (18.2% vs. 8.1%; relative risk, 2.24 [95% CI, 1.71 to 2.92]). Compared with usual care, intervention participants achieved larger reductions in HbA1c level (-0.50% [CI, -0.69% to -0.32%]), systolic BP (-4.04 mm Hg [CI, -5.85 to -2.22 mm Hg]), diastolic BP (-2.03 mm Hg [CI, -3.00 to -1.05 mm Hg]), and LDLc level (-7.86 mg/dL [CI, -10.90 to -4.81 mg/dL]) and reported higher HRQL and treatment satisfaction. LIMITATION: Findings were confined to urban specialist diabetes clinics. CONCLUSION: Multicomponent QI improves achievement of diabetes care goals, even in resource-challenged clinics. PRIMARY FUNDING SOURCE: National Heart, Lung, and Blood Institute and UnitedHealth Group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A test of missing completely at random for multivariate data with missing values
Little, R. J. A. (1988) · Journal of the American Statistical Association · doi:10.1080/01621459.1988.10478722 · Cited by 8,963 · cited 1×
“We assessed the mechanism of missingness by using the Little test (34).”
Method10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081
Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378 · cited 3×
“Few trials have evaluated comprehensive cardiometabolic improvements in patients with diabetes (15, 38, 39).”
BackgroundMultiple imputation by chained equations: what is it and how does it work?
Azur, M. J., Stuart, E. A., Frangakis, C., & Leaf, P. J. (2011) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.329 · Cited by 3,542 · cited 1×
“We also conducted additional analyses to examine the sensitivity of our primary results to missing outcome data by applying 2 methods: inverse probability weighting (35) and multiple imputation using chained equations (36).”
MethodStandards of medical care in diabetes 2010
American Diabetes Association (2010) · Diabetes Care · doi:10.2337/dc10-s011 · Cited by 3,470
Effect of a multifactorial intervention on mortality in type 2 diabetes
Gæde, P., Lund-Andersen, H., Parving, H.-H., & Pedersen, O. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0706245 · Cited by 3,465
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066 · cited 1×
“Although much improvement is possible, achieving generic dichotomous targets (such as an HbA1c level <7%) is increasingly less relevant in contemporary practice (43); instead, individualized, patient-centered goals are strongly emphasized (44, 45).”
BackgroundChanges in diabetes-related complications in the United States, 1990-2010
Gregg, E. W., Li, Y., Wang, J., Rios Burrows, N., Ali, M. K., Rolka, D., Williams, D. E., & Geiss, L. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1310799 · Cited by 1,749 · cited 4×
“Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990–2010.”
BackgroundInfluentialSelf-citationKinaan, M., Ding, H., & Triggle, C. R. (2015) · Medical Principles and Practice · doi:10.1159/000381643 · Cited by 1,515
Renders, C. M., Valk, G. D., Griffin, S. J., Wagner, E. H., Eijk van, J. T., & Assendelft, W. J. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.10.1821 · Cited by 1,066
Achievement of Goals in U.S. Diabetes Care, 1999–2010
Ali, M. K., Bullard, K. M., Saaddine, J. B., Cowie, C. C., Imperatore, G., & Gregg, E. W. (2013) · New England Journal of Medicine · doi:10.1056/nejmsa1213829 · Cited by 979 · cited 4×
“Gregg EW, Li Y, Wang J, Burrows NR, Ali MK, Rolka D, et al. Changes in diabetes-related complications in the United States, 1990–2010.”
BackgroundInfluentialSelf-citationTricco, A. C., Ivers, N. M., Grimshaw, J. M., Moher, D., Turner, L., Galipeau, J., Halperin, I., Vachon, B., Ramsay, T., Manns, B., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60480-2 · Cited by 652 · cited 3×
“In a meta-analysis of 48 cluster and 94 individual randomized, controlled trials testing diabetes QI interventions, the longest follow-up was just 12 months and the largest individual-focused trial included only 206 participants (27).”
BackgroundGriffin, S. J., Borch-Johnsen, K., Davies, M. J., Khunti, K., Rutten, G. E., Sandbæk, A., Sharp, S. J., Simmons, R. K., van den Donk, M., Wareham, N. J., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60698-3 · Cited by 462 · cited 2×
“These between-group differences were associated with more modest (5% to 17%) and statistically nonsignificant reductions in cardiovascular and microvascular outcomes over 5 years (38, 41).”
Background8. Cardiovascular Disease and Risk Management
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s011 · Cited by 329
Mohiuddin, S. M., Mooss, A. N., Hunter, C. B., Grollmes, T. L., Cloutier, D. A., & Hilleman, D. E. (2007) · Chest · doi:10.1378/chest.06-1587 · Cited by 281 · cited 1×
“Diabetes management focuses on reducing patients' risk for microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular (coronary, cerebrovascular, and peripheral vascular diseases) complications through control of blood glucose levels (2–5), blood pressure (BP) (6–8), and lipid levels (9, 10) and avoida…”
BackgroundSchmittdiel, J. A., Uratsu, C. S., Karter, A. J., Heisler, M., Subramanian, U., Mangione, C. M., & Selby, J. V. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0554-8 · Cited by 239 · cited 1×
“tors: Poor patient adherence and lack of treatment intensification by providers each explain roughly half of cases of poor disease control among patients with diabetes (28, 29).”
Background3. Foundations of Care and Comprehensive Medical Evaluation
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc16-s006 · Cited by 159
Alshurafa, M., Briel, M., Akl, E. A., Haines, T., Moayyedi, P., Gentles, S. J., Rios, L., Tran, C., Bhatnagar, N., Lamontagne, F., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049163 · Cited by 126
Research works printed but not linked: 21
- 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- 10.1056/NEJM199309303291401 · DOI · Paper page
- 10.1001/archinte.165.12.1410 · DOI · Paper page
- 10.1001/jama.290.1.86 · DOI · Paper page
- 10.2337/dc12-1759 · DOI · Paper page
- 10.1016/j.diabres.2013.03.010 · DOI
- 10.7326/M14-0019 · DOI · Paper page
- 10.1016/j.diabres.2013.01.010 · DOI
- 10.1016/j.diabres.2014.11.004 · DOI · Paper page
- 10.7326/0003-4819-141-4-200408170-00007 · DOI · Paper page
- 10.1001/jama.296.4.427 · DOI · Paper page
- 10.2337/diacare.27.7.1535 · DOI · Paper page
- 10.1016/j.diabres.2012.09.023 · DOI · Paper page
- Hartwig SC, 1992, Am J Hosp Pharm, 49, 2229
- 10.1177/0962280210395740 · DOI · Paper page
- 10.1016/j.jacc.2015.06.019 · DOI · Paper page
- 10.1038/sj.ijo.0801420 · DOI · Paper page
- 10.2337/dc13-1544 · DOI · Paper page
- 10.1016/S0895-4356(03)00044-1 · DOI · Paper page
- 10.7326/0003-4819-154-8-201104190-00007 · DOI · Paper page
- 10.1377/hlthaff.2015.0570 · DOI
Cited by
Jagannathan, R., Patel, S. A., Ali, M. K., & Narayan, K. M. V. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1161-2 · Cited by 369
Self-citationDiabetes in developing countries
Misra, A., Gopalan, H., Jayawardena, R., Hills, A. P., Soares, M., Reza‐Albarrán, A. A., & Ramaiya, K. L. (2019) · Journal of Diabetes · doi:10.1111/1753-0407.12913 · Cited by 300
He, X., Li, J., Wang, B., Yao, Q., Li, L., Song, R., Shi, X., & Zhang, J.-A. (2017) · Endocrine · doi:10.1007/s12020-016-1168-2 · Cited by 250
Addressing Unmet Basic Resource Needs as Part of Chronic Cardiometabolic Disease Management
Berkowitz, S. A., Hulberg, A. C., Standish, S., Reznor, G., & Atlas, S. J. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.7691 · Cited by 237
Prabhakaran, D., Anand, S., Watkins, D., Gaziano, T., Wu, Y., Mbanya, J. C., Nugent, R., Ajay, V. S., Afshin, A., Adler, A., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32471-6 · Cited by 162
Self-citation
Metadata
- Authors
- Ali, M. K., Singh, K., Kondal, D., Devarajan, R., Patel, S. A., Shivashankar, R., Ajay, V. S., Unnikrishnan, A. G., Menon, V. U., Varthakavi, P. K., Viswanathan, V., Dharmalingam, M., Bantwal, G., Sahay, R. K., Masood, M. Q., Khadgawat, R., Desai, A., Sethi, B., Prabhakaran, D., Narayan, K. M. V., Tandon, N., & on behalf of the CARRS Trial Group*
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2016-09-20
- Volume
- 165
- Issue
- 6
- Pages
- 399-408
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2470269599
- Cited by
- 109
- References
- 24
- FWCI
- 10.68
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.